| 000 | 01631 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518070623.0 | ||
| 264 | 0 | _c20210204 | |
| 008 | 202102s 0 0 eng d | ||
| 022 | _a1872-8332 | ||
| 024 | 7 |
_a10.1016/j.lungcan.2019.10.030 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSousa, A C | |
| 245 | 0 | 0 |
_aDetection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _c01 2020 |
||
| 300 |
_a35-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aDNA Mutational Analysis _xmethods |
| 650 | 0 | 4 | _aDecision Making |
| 650 | 0 | 4 |
_aErbB Receptors _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSilveira, C | |
| 700 | 1 | _aJaneiro, A | |
| 700 | 1 | _aMalveiro, S | |
| 700 | 1 | _aOliveira, A R | |
| 700 | 1 | _aFelizardo, M | |
| 700 | 1 | _aNogueira, F | |
| 700 | 1 | _aTeixeira, E | |
| 700 | 1 | _aMartins, J | |
| 700 | 1 | _aCarmo-Fonseca, M | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 139 _gp. 35-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lungcan.2019.10.030 _zAvailable from publisher's website |
| 999 |
_c30301577 _d30301577 |
||